Reference : Comment je traite ... le myelome multiple refractaire par thalidomide
Scientific journals : Article
Human health sciences : Hematology
Comment je traite ... le myelome multiple refractaire par thalidomide
[en] How I Treat... Refractory Multiple Myeloma with Thalidomide
Scerbo, F. [> > > >]
Matus, G. [> > > >]
Sautois, Brieuc mailto [Centre Hospitalier Universitaire de Liège - CHU > > Oncologie médicale >]
Fillet, Georges mailto [Université de Liège - ULg > Département des sciences cliniques > Hématologie - Oncologie médicale]
Revue Médicale de Liège
Yes (verified by ORBi)
[en] Despite the use of high-dose chemotherapy with autologous hematopoietic stem cell transplantation, multiple myeloma remains largely uncurable. Indeed complete remission rate is about 50% and median survival reaches 5 years without plateau. Recently thalidomide has been identified as a promising agent. We report the clinical story of 2 patients with refractory myeloma that we treated successfully with thalidomide.

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.